CTLA4 and cancer: While blockades via the programmed cell death protein-1 (PD-1) receptor and cytotoxic T-lymphocyte antigen 4 (CTLA-4) have led to breakthroughs in cancer immunotherapy [130], interestingly, CAR-T cells also express PD-1 and CTLA-4, and others [131].